Clinical Trial Update: Metronomic Chemotherapy by Cyclophosphamide Versus Megestrol in Palliative Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial comparing metronomic cyclophosphamide with megestrol acetate in palliative cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• Cytoxan (cyclophosphamide)
• Megace (megestrol acetate)

Snippet

Sponsor: Centre Oscar Lambret | Conditions: Cancer | Phase 2 | Status: COMPLETED